ALXO
ALX ONCOLOGY HOLDINGS INC
-0.01 (-0.28%)1.76USD159K成交股數243M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-06下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 13.1M | 13.6M | 17.4M | 18.0M | 23.9M | 23.5M | 26.5M | 34.7M | 31.7M | 45.8M | 29.5M | 24.8M |
| 銷售管理費用 | 5.1M | 5.4M | 5.1M | 5.5M | 7.9M | 7.1M | 6.1M | 6.9M | 6.0M | 7.5M | 7.3M | 7.4M |
| 營業利益 | −18.0M-43% | −19.0M-38% | −22.5M-31% | −26.6M-36% | −31.8M-16% | −30.6M-43% | −32.6M-11% | −41.5M+29% | −37.8M | −53.3M | −36.8M | −32.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −18.0M-42% | −17.9M-39% | −22.1M-28% | −25.9M-34% | −30.8M-14% | −29.2M-43% | −30.7M-10% | −39.4M+31% | −35.6M | −51.0M | −34.2M | −30.2M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.13-78% | -0.17-68% | -0.41-29% | -0.49-36% | -0.58-18% | -0.53-57% | -0.58-31% | -0.76+3% | -0.71 | -1.24 | -0.84 | -0.74 |
| 稀釋股數 | 136M | 105M | 53.6M | 53.4M | 53.4M | 52.2M | 52.7M | 51.8M | 50.1M | 41.1M | 40.9M | 40.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 22.7M | 32.3M | 23.4M | 19.3M | 20.6M | 17.6M | 16.1M | 15.5M | 14.0M | 19.6M | 38.0M | 63.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 161M | 178M | 82.7M | 95.3M | 121M | 148M | 186M | 215M | 213M | 220M | 246M | 278M |
| 有息負債 | 9.7M | 3.3M | 5.8M | 7.0M | 8.2M | 9.5M | 9.8M | 9.8M | 9.7M | 9.6M | 9.5M | 9.5M |
| 總負債 | 24.6M | 27.0M | 37.9M | 30.9M | 32.6M | 34.2M | 48.9M | 55.3M | 48.5M | 51.4M | 33.2M | 37.8M |
| 股東權益 | 136M | 151M | 44.8M | 64.4M | 88.3M | 114M | 137M | 159M | 164M | 169M | 213M | 240M |
| 負債比 | 15.3% | 15.1% | 45.8% | 32.4% | 27.0% | 23.1% | 26.3% | 25.8% | 22.8% | 23.3% | 13.5% | 13.6% |
| 淨現金(現金 − 有息負債) | 13.0M | 29.0M | 17.7M | 12.3M | 12.4M | 8.1M | 6.3M | 5.8M | 4.3M | 10.0M | 28.5M | 53.7M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −18.6M | – | – | −24.7M-35% | – | – | – | −37.9M | – | – | −27.8M |
| 資本支出 | – | 50K | – | – | 60K | – | – | – | 148K | – | – | 690K |
| 自由現金流 | – | −18.7M | – | – | −24.7M-35% | – | – | – | −38.1M | – | – | −28.5M |
| 折舊攤銷 | 100K | 150K | 200K | 200K | 211K | 258K | 200K | 200K | 214K | 200K | 200K | 213K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −102M | –% | -1.90 | −84.4M |
| FY2024 | – | – | −135M | –% | -2.58 | −122M |
| FY2023 | – | – | −161M | –% | -3.74 | −132M |
| FY2022 | 0.00 | – | −123M | –% | -3.03 | −90.7M |
| FY2021 | 0.00 | -100.0% | −83.5M | –% | -2.07 | −68.8M |
| FY2020 | 1.2M | -75.4% | −45.7M | -3,869.7% | -2.76 | −38.3M |
| FY2019 | 4.8M | +132.0% | −19.2M | -401.2% | -7.56 | −14.6M |
| FY2018 | 2.1M | – | −13.7M | -664.3% | -6.33 | −13.8M |